CPHI
Price:
$0.19
Market Cap:
$3.66M
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Dieste...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-04-17
Stock Exchange
AMEX
Ticker
CPHI
According to China Pharma Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.95M. This represents a change of -6.93% compared to the average of 7.47M of the last 4 quarters.
The mean historical Enterprise Value of China Pharma Holdings, Inc. over the last ten years is 61.17M. The current 6.95M Enterprise Value has changed 1.04% with respect to the historical average. Over the past ten years (40 quarters), CPHI's Enterprise Value was at its highest in in the March 2021 quarter at 198.12M. The Enterprise Value was at its lowest in in the March 2024 quarter at 5.54M.
Average
61.17M
Median
58.90M
Minimum
5.26M
Maximum
118.94M
Discovering the peaks and valleys of China Pharma Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 88.31%
Maximum Annual Enterprise Value = 118.94M
Minimum Annual Increase = -83.55%
Minimum Annual Enterprise Value = 5.26M
Year | Enterprise Value | Change |
---|---|---|
2023 | 5.26M | -83.55% |
2022 | 31.96M | -73.13% |
2021 | 118.94M | 14.69% |
2020 | 103.71M | 88.31% |
2019 | 55.07M | -12.19% |
2018 | 62.72M | 35.86% |
2017 | 46.16M | -29.15% |
2016 | 65.16M | 45.09% |
2015 | 44.91M | -42.32% |
2014 | 77.86M | -9.92% |
The current Enterprise Value of China Pharma Holdings, Inc. (CPHI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
52.05M
5-year avg
62.99M
10-year avg
61.17M
China Pharma Holdings, Inc.’s Enterprise Value is greater than Universe Pharmaceuticals INC (-1030316.00), greater than Sonoma Pharmaceuticals, Inc. (-231633.00), less than Acorda Therapeutics, Inc. (187.38M), greater than Akanda Corp. (-3417326.00), less than Halo Collective Inc. (16.67M), less than Alimera Sciences, Inc. (362.58M), greater than China SXT Pharmaceuticals, Inc. (-8074167.00), greater than Petros Pharmaceuticals, Inc. (6.23M), greater than Biofrontera Inc. (5.72M), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than Shuttle Pharmaceuticals Holdings, Inc. (3.33M), greater than Green Cures & Botanical Distribution Inc. (789.33K), greater than Cann American Corp. (2.14M), greater than Rimrock Gold Corp. (273.27K), greater than Galexxy Holdings, Inc. (2.46M), greater than Indoor Harvest Corp (727.03K), less than Mallinckrodt plc (2.67B), less than Lifecore Biomedical, Inc. (407.55M), greater than Lucy Scientific Discovery Inc. (2.06M), greater than Adamis Pharmaceuticals Corporation (-6593458674.00),
Company | Enterprise Value | Market cap |
---|---|---|
-1030316.00 | $1.32M | |
-231633.00 | $3.60M | |
187.38M | $821.03K | |
-3417326.00 | $2.24M | |
16.67M | $15.08K | |
362.58M | $301.29M | |
-8074167.00 | $1.35M | |
6.23M | $2.88M | |
5.72M | $7.60M | |
-10475955.00 | $4.35M | |
3.33M | $2.92M | |
789.33K | $783.95K | |
2.14M | $2.14M | |
273.27K | $273.27K | |
2.46M | $1.50M | |
727.03K | $320.57K | |
2.67B | $4.52M | |
407.55M | $276.20M | |
2.06M | $906.91K | |
-6593458674.00 | $7.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China Pharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like China Pharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is China Pharma Holdings, Inc.'s Enterprise Value?
What is the highest Enterprise Value for China Pharma Holdings, Inc. (CPHI)?
What is the 3-year average Enterprise Value for China Pharma Holdings, Inc. (CPHI)?
What is the 5-year average Enterprise Value for China Pharma Holdings, Inc. (CPHI)?
How does the current Enterprise Value for China Pharma Holdings, Inc. (CPHI) compare to its historical average?